XDx Registers for IPO

Brisbane, Calif.-based biotech firm XDx Inc. on Wednesday announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock.

XDx specializes in molecular diagnostics for the monitoring of transplant rejection and autoimmune diseases.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

School board backs continued distance learning for fall

After a lengthy discussion Tuesday, the Board of Education is backing plans… Continue reading

Crowded neighborhoods left out of Slow Streets

Tenderloin, SoMa seen as bad fit for car-free program

City attorney seeks to block contractor in Nuru scandal from obtaining government contracts

City Attorney Dennis Herrera has moved to prohibit AzulWorks, Inc. and its… Continue reading

Supes approve $2.1M settlement over sewage spills at SF’s Hall of Justice jail

San Francisco has tentatively agreed to pay out a total of $2.1… Continue reading

US backs down in fight with Harvard, MIT over student visas

The U.S. backed down from a high-profile confrontation with two elite universities… Continue reading

Most Read